SS Innovations International Files 8-K

Ticker: SSII · Form: 8-K · Filed: 2025-12-16T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, disclosure

TL;DR

SS Innovations (fka AVRA Medical Robotics) filed an 8-K on 12/16/25 for a Reg FD disclosure.

AI Summary

SS Innovations International, Inc. filed an 8-K on December 16, 2025, reporting a Regulation FD Disclosure. The company, formerly known as AVRA Medical Robotics, Inc. since June 1, 2016, is incorporated in Florida and has its principal executive offices in Gurugram, Haryana, India.

Why It Matters

This filing indicates a regulatory disclosure event for SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for a Regulation FD disclosure, which typically does not involve significant new financial or operational information.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on December 16, 2025.

What was SS Innovations International, Inc. formerly known as?

SS Innovations International, Inc. was formerly known as AVRA Medical Robotics, Inc.

On what date did the company change its name from AVRA Medical Robotics, Inc.?

The company changed its name from AVRA Medical Robotics, Inc. on June 1, 2016.

Where are the principal executive offices of SS Innovations International, Inc. located?

The principal executive offices of SS Innovations International, Inc. are located at 05, 3rd Floor, iLabs Info Technology Centre, Udyog Vihar, Phase III, Gurugram, Haryana, India.

From the Filing

0001213900-25-122031.txt : 20251216 0001213900-25-122031.hdr.sgml : 20251216 20251216103633 ACCESSION NUMBER: 0001213900-25-122031 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20251216 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20251216 DATE AS OF CHANGE: 20251216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SS Innovations International, Inc. CENTRAL INDEX KEY: 0001676163 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 473478854 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42615 FILM NUMBER: 251573716 BUSINESS ADDRESS: STREET 1: 1600 SE 15TH STREET STREET 2: #512 CITY: FORT LAUDERDALE STATE: FL ZIP: 33316 BUSINESS PHONE: (954) 478-1410 MAIL ADDRESS: STREET 1: 1600 SE 15TH STREET STREET 2: #512 CITY: FORT LAUDERDALE STATE: FL ZIP: 33316 FORMER COMPANY: FORMER CONFORMED NAME: AVRA Medical Robotics, Inc. DATE OF NAME CHANGE: 20160601 8-K 1 ea0269726-8k_ssinno.htm CURRENT REPORT false 0001676163 0001676163 2025-12-16 2025-12-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of report (Date of earliest event reported): December 16, 2025   SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter)   Florida   001-42615   47-3478854 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   05, 3rd Floor, iLabs Info Technology Centre Udyog Vihar, Phase III , Gurugram , Haryana, India     122016 Address of Principal Executive Office (Street and Number)   (Zip Code)   Registrant’s telephone number, including area code: +91 73375 53469     (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each Class   Trading Symbol   Name of each exchange on which registered Common Stock   SSII   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   As used in this Current Report on Form 8-K (this “ Report ”), the terms “ SSi ,” “ the Company ,” “ we ,” “ us ” and “ our ” refer to SS Innovations International, Inc. and its subsidiaries.               Item 7.01. Regulation FD Disclosure.   On November 13, 2025, Dr. Sudhir Srivastava our Chairman and Chief Executive Officer, g

View on Read The Filing